KPL-1161

N/A

Report date: 2025/04/17 16:06:01

Base Information

Drug NameKPL-1161
Drug Alias NameKPL-1161
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-1 receptor bindersInterleukin-1 alpha inhibitorsInterleukin-1 beta inhibitors
TargetsInterleukin-1 receptorInterleukin-1 betaInterleukin-1 alpha
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKiniksa Pharmaceuticals International PLC
China Registration ClassN/A

Develop Information

Active CompaniesKiniksa Pharmaceuticals International PLC
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A